Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Its clinical development for obesity was discontinued in 2007 after the pivotal 536-participant Phase IIb trial failed to meet its primary efficacy endpoint, and no formulation of the compound has received FDA approval since
Further research is needed to confirm its safety and efficacy for approval by FDA, till then epithalon purchase is available for research purpose only
This outcome robustly supports our hypothesis regarding the induction of apoptosis via pDNA/Polybia-MP1
Moloi, M
This higher purity level enables precise dosing and reduces the risk of contamination or unwanted interactions with other substances
Ipamorelin is called the first truly selective growth hormone secretagogue because it stimulates GH release without measurably raising cortisol, prolactin, or ACTH at therapeutic doses
US$ 26.25
US$ 23.98
US$ 21.74
US$ 25.67
US$ 26.29
US$ 29.71
US$ 24.82
US$ 22.40
US$ 26.22
